Axbio Presents the Applications of its Advanced Clinical Diagnostics Platforms for Genetic and Protein Biomarkers Testing at BAAM 2024.

Berkeley, CA – May 14, 2024 – Axbio Inc. participated in the 24th Bay Area Aging Meeting (BAAM) 2024, held at the University of California, Berkeley, reinforcing its commitment to advancing aging research and precision health. The event gathered leading experts, researchers, and industry professionals to discuss the latest breakthroughs in longevity science.

As part of the scientific program, Axbio presented a poster titled "Genetic and Protein Biomarkers Profiling for Wellness and Longevity," showcasing its latest advancements in multi-omics analysis and AI-driven biomarker discovery. The presentation highlighted Axbio's innovative approach to identifying key molecular signatures associated with aging of organ systems, with the goal of enabling personalized interventions for a better longevity and proactive health management.

"Axbio's instrument platforms enable multi-omics profiling to provide a comprehensive picture of aging-related biological processes in different organ systems," said Dr. Nikolay Sergeev, Vice President of Applications at Axbio. "By leveraging AI and cutting-edge multi-omics diagnostics, we aim to empower individuals with actionable insights to optimize their health and longevity."

The BAAM 2024 meeting provided an invaluable opportunity for collaborations and discussions with experts in genetics, metabolism, brain aging, and longevity medicine. Axbio remains dedicated to pioneering next-generation solutions in aging science and precision medicine.

For more information about Axbio's work in aging and biomarker discovery, visit www.axbio.com.